The Europe Penicillin Drug Market would witness market growth of 3.2% CAGR during the forecast period (2023-2030).
Healthcare professionals are more likely to prescribe penicillin when necessary due to a better understanding of the proper indications, dose, and duration of penicillin therapy. This will contribute to the market’s growth. Patients also play a critical role in supporting market growth by immediately seeking medical treatment for bacterial illnesses and adhering to the recommended penicillin prescription.
Antibiotic use needs to be optimized, enhanced infection control strategies and the creation of new antimicrobial agents are some of the various approaches needed to combat antimicrobial resistance. As a result, the pharmaceutical industry realizes the significance of constantly enhancing and broadening the options accessible for penicillin therapy, which is predicted to fuel the expansion of the market throughout the forecast period.
Lack of good health, failing to wash hands before eating or cooking, concealing sneezing, and inadequate sanitation and hygiene routines are the main causes of increased bacterial illness. Due to this increased incidence, there is a significantly higher need for antibiotics, leading to profitable growth prospects for the market during the forecast period.
The pharmaceutical industry in Europe has a significant role in the economy and the public's interest in health care. The pharmaceutical industry's sales climbed by 5.7 percent in 2019 to reach EUR 46.4 billion. On the other hand, a general relocation of pharmaceutical manufacturers would increase expenses for the healthcare system, negatively impacting its ability to compete. In Germany, the healthcare industry accounts for one in every six employment and has an economic impact of EUR 678.2 billion (USD 798 billion), or around 12% of Germany's GDP. The market will grow as the region's healthcare industries expand.
The Germany market dominated the Europe Penicillin Drug Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $676.9 million by 2030. The UK market is estimated to grow CAGR of 2.3% during (2023 - 2030). Additionally, The France market would showcase a CAGR of 3.9% during (2023 - 2030).
Based on Source, the market is segmented into Semisynthetic Penicillin and Natural Penicillin. Based on Spectrum of Activity, the market is segmented into Broad spectrum, Extended spectrum and Narrow spectrum. Based on Distribution Channel, the market is segmented into Drug Stores & Retail Pharmacies, Hospital Pharmacies and Online Providers. Based on Route of Administration, the market is segmented into Parenteral and Oral. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Worldwide Penicillin Drug Market is Projected to reach USD 10.9 Billion by 2030, at a CAGR of 3.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include GlaxoSmithKline PLC (GSK), Pfizer, Inc., Novartis AG, Lupin Limited, Abbott Laboratories, Cipla Limited, Takeda Pharmaceutical Company Limited, Alkem Laboratories Ltd., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Source
- Semisynthetic Penicillin
- Natural Penicillin
By Spectrum of Activity
- Broad spectrum
- Extended spectrum
- Narrow spectrum
By Distribution Channel
- Drug Stores & Retail Pharmacies
- Hospital Pharmacies
- Online Providers
By Route of Administration
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- GlaxoSmithKline PLC (GSK)
- Pfizer, Inc.
- Novartis AG
- Lupin Limited
- Abbott Laboratories
- Cipla Limited
- Takeda Pharmaceutical Company Limited
- Alkem Laboratories Ltd.
- Teva Pharmaceuticals Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Penicillin Drug Market, by Source
1.4.2 Europe Penicillin Drug Market, by Spectrum of Activity
1.4.3 Europe Penicillin Drug Market, by Distribution Channel
1.4.4 Europe Penicillin Drug Market, by Route of Administration
1.4.5 Europe Penicillin Drug Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Trials and Approvals
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2020, Jun – 2023, Mar) Leading Players
4.4 Porter Five Forces Analysis
Chapter 5. Europe Penicillin Drug Market by Source
5.1 Europe Semisynthetic Penicillin Market by Country
5.2 Europe Natural Penicillin Market by Country
Chapter 6. Europe Penicillin Drug Market by Spectrum of Activity
6.1 Europe Broad spectrum Market by Country
6.2 Europe Extended spectrum Market by Country
6.3 Europe Narrow spectrum Market by Country
Chapter 7. Europe Penicillin Drug Market by Distribution Channel
7.1 Europe Drug Stores & Retail Pharmacies Market by Country
7.2 Europe Hospital Pharmacies Market by Country
7.3 Europe Online Providers Market by Country
Chapter 8. Europe Penicillin Drug Market by Route of Administration
8.1 Europe Parenteral Market by Country
8.2 Europe Oral Market by Country
Chapter 9. Europe Penicillin Drug Market by Country
9.1 Germany Penicillin Drug Market
9.1.1 Germany Penicillin Drug Market by Source
9.1.2 Germany Penicillin Drug Market by Spectrum of Activity
9.1.3 Germany Penicillin Drug Market by Distribution Channel
9.1.4 Germany Penicillin Drug Market by Route of Administration
9.2 UK Penicillin Drug Market
9.2.1 UK Penicillin Drug Market by Source
9.2.2 UK Penicillin Drug Market by Spectrum of Activity
9.2.3 UK Penicillin Drug Market by Distribution Channel
9.2.4 UK Penicillin Drug Market by Route of Administration
9.3 France Penicillin Drug Market
9.3.1 France Penicillin Drug Market by Source
9.3.2 France Penicillin Drug Market by Spectrum of Activity
9.3.3 France Penicillin Drug Market by Distribution Channel
9.3.4 France Penicillin Drug Market by Route of Administration
9.4 Russia Penicillin Drug Market
9.4.1 Russia Penicillin Drug Market by Source
9.4.2 Russia Penicillin Drug Market by Spectrum of Activity
9.4.3 Russia Penicillin Drug Market by Distribution Channel
9.4.4 Russia Penicillin Drug Market by Route of Administration
9.5 Spain Penicillin Drug Market
9.5.1 Spain Penicillin Drug Market by Source
9.5.2 Spain Penicillin Drug Market by Spectrum of Activity
9.5.3 Spain Penicillin Drug Market by Distribution Channel
9.5.4 Spain Penicillin Drug Market by Route of Administration
9.6 Italy Penicillin Drug Market
9.6.1 Italy Penicillin Drug Market by Source
9.6.2 Italy Penicillin Drug Market by Spectrum of Activity
9.6.3 Italy Penicillin Drug Market by Distribution Channel
9.6.4 Italy Penicillin Drug Market by Route of Administration
9.7 Rest of Europe Penicillin Drug Market
9.7.1 Rest of Europe Penicillin Drug Market by Source
9.7.2 Rest of Europe Penicillin Drug Market by Spectrum of Activity
9.7.3 Rest of Europe Penicillin Drug Market by Distribution Channel
9.7.4 Rest of Europe Penicillin Drug Market by Route of Administration
Chapter 10. Company Profiles
10.1 Novartis AG
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent strategies and developments:
10.1.5.1 Partnerships, Collaborations, and Agreements:
10.1.5.2 Acquisition and Mergers:
10.1.6 SWOT Analysis
10.2 Teva Pharmaceutical Industries Ltd.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Regional Analysis
10.2.4 Research & Development Expenses
10.2.5 SWOT Analysis
10.3 Sun Pharmaceutical Industries Ltd.
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Regional Analysis
10.3.4 Research & Development Expenses
10.3.5 Recent strategies and developments:
10.3.5.1 Acquisition and Mergers:
10.3.6 SWOT Analysis
10.4 GlaxoSmithKline PLC (GSK)
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Partnerships, Collaborations, and Agreements:
10.4.6 SWOT Analysis
10.5 Pfizer, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Regional & Segmental Analysis
10.5.4 Research & Development Expense
10.5.5 Recent strategies and developments:
10.5.5.1 Partnerships, Collaborations, and Agreements:
10.5.5.2 Acquisition and Mergers:
10.5.5.3 Trials and Approvals:
10.5.6 SWOT Analysis
10.6 Lupin Limited
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Recent strategies and developments:
10.6.3.1 Partnerships, Collaborations, and Agreements:
10.6.4 SWOT Analysis
10.7 Abbott Laboratories
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.7.4 Research & Development Expense
10.7.5 SWOT Analysis
10.8 Cipla Limited
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Regional Analysis
10.8.4 Research & Development Expense
10.8.5 Recent strategies and developments:
10.8.5.1 Partnerships, Collaborations, and Agreements:
10.8.5.2 Acquisition and Mergers:
10.8.6 SWOT Analysis
10.9 Alkem Laboratories Ltd.
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Regional Analysis
10.9.4 Research & Development Expenses
10.9.5 Recent strategies and developments:
10.9.5.1 Product Launches and Product Expansions:
10.9.6 SWOT Analysis
10.10. Takeda Pharmaceutical Company Limited
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Regional Analysis
10.10.4 Research & Development Expense
10.10.5 Recent strategies and developments:
10.10.5.1 Acquisition and Mergers:
10.10.6 SWOT Analysis
TABLE 1 Europe Penicillin Drug Market, 2019 - 2022, USD Million
TABLE 2 Europe Penicillin Drug Market, 2023 - 2030, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Penicillin Drug Market
TABLE 4 Product Launches And Product Expansions– Penicillin Drug Market
TABLE 5 Acquisition and Mergers– Penicillin Drug Market
TABLE 6 Trials and Approvals- Penicillin Drug Market
TABLE 7 Europe Penicillin Drug Market by Source, 2019 - 2022, USD Million
TABLE 8 Europe Penicillin Drug Market by Source, 2023 - 2030, USD Million
TABLE 9 Europe Semisynthetic Penicillin Market by Country, 2019 - 2022, USD Million
TABLE 10 Europe Semisynthetic Penicillin Market by Country, 2023 - 2030, USD Million
TABLE 11 Europe Natural Penicillin Market by Country, 2019 - 2022, USD Million
TABLE 12 Europe Natural Penicillin Market by Country, 2023 - 2030, USD Million
TABLE 13 Europe Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
TABLE 14 Europe Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
TABLE 15 Europe Broad spectrum Market by Country, 2019 - 2022, USD Million
TABLE 16 Europe Broad spectrum Market by Country, 2023 - 2030, USD Million
TABLE 17 Europe Extended spectrum Market by Country, 2019 - 2022, USD Million
TABLE 18 Europe Extended spectrum Market by Country, 2023 - 2030, USD Million
TABLE 19 Europe Narrow spectrum Market by Country, 2019 - 2022, USD Million
TABLE 20 Europe Narrow spectrum Market by Country, 2023 - 2030, USD Million
TABLE 21 Europe Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 22 Europe Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 23 Europe Drug Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 24 Europe Drug Stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 25 Europe Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 26 Europe Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
TABLE 27 Europe Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 28 Europe Online Providers Market by Country, 2023 - 2030, USD Million
TABLE 29 Europe Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
TABLE 30 Europe Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
TABLE 31 Europe Parenteral Market by Country, 2019 - 2022, USD Million
TABLE 32 Europe Parenteral Market by Country, 2023 - 2030, USD Million
TABLE 33 Europe Oral Market by Country, 2019 - 2022, USD Million
TABLE 34 Europe Oral Market by Country, 2023 - 2030, USD Million
TABLE 35 Europe Penicillin Drug Market by Country, 2019 - 2022, USD Million
TABLE 36 Europe Penicillin Drug Market by Country, 2023 - 2030, USD Million
TABLE 37 Germany Penicillin Drug Market, 2019 - 2022, USD Million
TABLE 38 Germany Penicillin Drug Market, 2023 - 2030, USD Million
TABLE 39 Germany Penicillin Drug Market by Source, 2019 - 2022, USD Million
TABLE 40 Germany Penicillin Drug Market by Source, 2023 - 2030, USD Million
TABLE 41 Germany Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
TABLE 42 Germany Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
TABLE 43 Germany Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 44 Germany Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 45 Germany Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
TABLE 46 Germany Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
TABLE 47 UK Penicillin Drug Market, 2019 - 2022, USD Million
TABLE 48 UK Penicillin Drug Market, 2023 - 2030, USD Million
TABLE 49 UK Penicillin Drug Market by Source, 2019 - 2022, USD Million
TABLE 50 UK Penicillin Drug Market by Source, 2023 - 2030, USD Million
TABLE 51 UK Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
TABLE 52 UK Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
TABLE 53 UK Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 54 UK Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 55 UK Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
TABLE 56 UK Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
TABLE 57 France Penicillin Drug Market, 2019 - 2022, USD Million
TABLE 58 France Penicillin Drug Market, 2023 - 2030, USD Million
TABLE 59 France Penicillin Drug Market by Source, 2019 - 2022, USD Million
TABLE 60 France Penicillin Drug Market by Source, 2023 - 2030, USD Million
TABLE 61 France Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
TABLE 62 France Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
TABLE 63 France Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 64 France Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 65 France Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
TABLE 66 France Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
TABLE 67 Russia Penicillin Drug Market, 2019 - 2022, USD Million
TABLE 68 Russia Penicillin Drug Market, 2023 - 2030, USD Million
TABLE 69 Russia Penicillin Drug Market by Source, 2019 - 2022, USD Million
TABLE 70 Russia Penicillin Drug Market by Source, 2023 - 2030, USD Million
TABLE 71 Russia Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
TABLE 72 Russia Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
TABLE 73 Russia Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 74 Russia Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 75 Russia Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
TABLE 76 Russia Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
TABLE 77 Spain Penicillin Drug Market, 2019 - 2022, USD Million
TABLE 78 Spain Penicillin Drug Market, 2023 - 2030, USD Million
TABLE 79 Spain Penicillin Drug Market by Source, 2019 - 2022, USD Million
TABLE 80 Spain Penicillin Drug Market by Source, 2023 - 2030, USD Million
TABLE 81 Spain Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
TABLE 82 Spain Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
TABLE 83 Spain Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 84 Spain Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 85 Spain Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
TABLE 86 Spain Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
TABLE 87 Italy Penicillin Drug Market, 2019 - 2022, USD Million
TABLE 88 Italy Penicillin Drug Market, 2023 - 2030, USD Million
TABLE 89 Italy Penicillin Drug Market by Source, 2019 - 2022, USD Million
TABLE 90 Italy Penicillin Drug Market by Source, 2023 - 2030, USD Million
TABLE 91 Italy Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
TABLE 92 Italy Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
TABLE 93 Italy Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 94 Italy Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 95 Italy Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
TABLE 96 Italy Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
TABLE 97 Rest of Europe Penicillin Drug Market, 2019 - 2022, USD Million
TABLE 98 Rest of Europe Penicillin Drug Market, 2023 - 2030, USD Million
TABLE 99 Rest of Europe Penicillin Drug Market by Source, 2019 - 2022, USD Million
TABLE 100 Rest of Europe Penicillin Drug Market by Source, 2023 - 2030, USD Million
TABLE 101 Rest of Europe Penicillin Drug Market by Spectrum of Activity, 2019 - 2022, USD Million
TABLE 102 Rest of Europe Penicillin Drug Market by Spectrum of Activity, 2023 - 2030, USD Million
TABLE 103 Rest of Europe Penicillin Drug Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 104 Rest of Europe Penicillin Drug Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 105 Rest of Europe Penicillin Drug Market by Route of Administration, 2019 - 2022, USD Million
TABLE 106 Rest of Europe Penicillin Drug Market by Route of Administration, 2023 - 2030, USD Million
TABLE 107 Key Information – Novartis AG
TABLE 108 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 109 Key Information – Sun Pharmaceutical Industries Ltd.
TABLE 110 Key Information – GlaxoSmithKline PLC
TABLE 111 Key Information – Pfizer, Inc.
TABLE 112 Key Information – Lupin Limited
TABLE 113 Key Information – Abbott Laboratories
TABLE 114 Key Information – Cipla Limited
TABLE 115 Key Information – Alkem Laboratories Ltd.
TABLE 116 Key Information – Takeda Pharmaceutical Company Limited
List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Penicillin Drug Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Penicillin Drug Market
FIG 4 KBV Cardinal Matrix
FIG 5 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 6 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2020, Jun – 2023, Mar) Leading Players
FIG 7 Porter’s Five Forces Analysis – Penicillin Drug Market
FIG 8 Europe Penicillin Drug Market SHARE by Source, 2022
FIG 9 Europe Penicillin Drug Market SHARE by Source, 2030
FIG 10 Europe Penicillin Drug Market by Source, 2019 - 2030, USD Million
FIG 11 Europe Penicillin Drug Market SHARE by Spectrum of Activity, 2022
FIG 12 Europe Penicillin Drug Market SHARE by Spectrum of Activity, 2030
FIG 13 Europe Penicillin Drug Market by Spectrum of Activity, 2019 - 2030, USD Million
FIG 14 Europe Penicillin Drug Market SHARE by Distribution Channel, 2022
FIG 15 Europe Penicillin Drug Market SHARE by Distribution Channel, 2030
FIG 16 Europe Penicillin Drug Market by Distribution Channel, 2019 - 2030, USD Million
FIG 17 Europe Penicillin Drug Market SHARE by Route of Administration, 2030
FIG 18 Europe Penicillin Drug Market SHARE by Route of Administration, 2022
FIG 19 Europe Penicillin Drug Market by Route of Administration, 2019 - 2030, USD Million
FIG 20 Europe Penicillin Drug Market SHARE by Country, 2022
FIG 21 Europe Penicillin Drug Market SHARE by Country, 2030
FIG 22 Europe Penicillin Drug Market by Country, 2019 - 2030, USD Million
FIG 23 SWOT Analysis: Novartis AG
FIG 24 SWOT Analysis: Teva Pharmaceuticals Industries Ltd.
FIG 25 SWOT Analysis: Sun Pharmaceutical Industries Ltd.
FIG 26 SWOT Analysis: GlaxoSmithKline PLC
FIG 27 Recent strategies and developments: Pfizer, Inc.
FIG 28 SWOT Analysis: Pfizer, Inc.
FIG 29 SWOT Analysis: Lupin Limited
FIG 30 SWOT Analysis: Abbott Laboratories
FIG 31 SWOT Analysis: Cipla Limited
FIG 32 SWOT Analysis: Alkem Laboratories Ltd.
FIG 33 SWOT Analysis: Takeda Pharmaceutical Company Limited